This ADC binds HER2 (not topoisomerase I) on tumor cells, is internalized, and releases a topoisomerase I–inhibiting payload that causes DNA damage and apoptosis. Topoisomerase I is the intracellular enzymatic target of the payload, not the cell-surface antigen used for targeting.